Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • fixed dose

    Tag: fixed dose combination

    You Searched For "fixed dose combination"
    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    MD bureau23 Feb 2020 6:15 AM GMT
    New Delhi: In continuation of the series of directives that the FDC Division, Central Drugs Standard Control Organization (CDSCO), Directorate General...
    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

    Farhat Nasim11 July 2019 12:08 PM GMT
    New Delhi: The Swiss drugmaker, Novartis recently presented before the Central Drugs Standard Control Organization(CDSCO) Technical Committee to seek...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 12:14 PM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

    Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

    Meghna A Singhania25 May 2019 5:45 AM GMT
    New Delhi: Dilip Shanghvi led Sun Pharma recently submitted a proposal to seek permission from the national regulatory authority, Central Drugs...
    Procedure for approval of FDC drugs: CDSCO releases notification; Details

    Procedure for approval of FDC drugs: CDSCO releases notification; Details

    Meghna A Singhania24 May 2019 12:42 PM GMT
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has directed drug manufacturers and all the...
    CDSCO denies approval for Akums Acid reflux FDC in Capsule form

    CDSCO denies approval for Akums Acid reflux FDC in Capsule form

    Meghna A Singhania8 May 2019 4:45 AM GMT
    New Delhi: In order to expand its portfolio, Akum Drugs & Pharmaceuticals Ltd. presented before the Subject Experts Committee (SEC) functional...
    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    Meghna A Singhania5 May 2019 7:22 AM GMT
    New Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
    CDSCO expert committee suggests ban of yet another 324 FDCs

    CDSCO expert committee suggests ban of yet another 324 FDCs

    Meghna A Singhania15 April 2019 6:19 AM GMT
    New Delhi: Domestic drugmakers are likely to face a blow as 324 Fixed Dose Combination (FDCs) drugs have been recommended to be banned by an expert...
    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Meghna A Singhania23 Feb 2019 7:27 AM GMT
    The high court has now ruled in favour of Lupin and quashed the apex court's decision to ban Lupin's anti-diabetic drug- Gluconorm P 30.New Delhi: In...
    80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry

    80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry

    Farhat Nasim18 Jan 2019 5:29 AM GMT
    According to the notification, some of the fixed dose combination drugs that have been banned include antibiotics like Cefglobe OZ, Taxim -OZ, drugs...
    Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs

    Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs

    Ruby Khatun Khatun8 Sep 2018 12:43 PM GMT
    The 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
    SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination

    SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination

    Ruby Khatun Khatun16 Dec 2017 10:10 AM GMT
    New Delhi: The Supreme Court referred 344 fixed dose combination (FDC) medicines, including well- known brands like Corex cough syrup, Vicks Action...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X